Benzinga's Microcap Movers for Tuesday July 24, 2012
Below are highlights from Benzinga's daily coverage of small cap and microcap securities making big moves:
Shares of SUTIMCo (SUTI), the Santa Ana, CA multi-project business development company, rose 202% Tuesday on 26 million shares.
SUTIMCo Investor Relations told Benzinga "there hasn't been any announcement today that would have created the increase in price per share. I believe the momentum is due to an increase in awareness."
SUTIMCo closed at $0.02 on Tuesday.
Catalyst Pharmaceutical Partners
Catalyst Pharmaceutical Partners (NASDAQ: CPRX), the Coral Gables, FL development-stage specialty pharmaceutical company, rose 22.73% Tuesday on 14 times average volume.
A positive Seeking Alpha article appears to be the reason for the move.
Catalyst Pharmaceutical Partners closed at $1.35 on Tuesday.
Shares of Ultrapetrol (NASDAQ: ULTR), the Bahamas-based marine transportation services company, rose 36.90% Tuesday on 3 times average volume.
Ultrapetrol announced Tuesday the sale of a further 14 wet and dry barges to a third party in Colombia. The barges are scheduled for delivery starting at the end of 2012 and extending through the second quarter of 2013. This sale will provide the Company with proceeds of $20.3 million, of which 50% will be advanced by the buyer. With this sale, the yard is fully employed until the end of the first quarter of 2013.
Ultrapetrol closed at $1.15 on Tuesday.
The information in this article is taken from public sources, press releases, and websites that cannot always be verified. Please note that investing in microcap stocks is highly speculative. The companies mentioned here are for information purposes only. Benzinga makes no claim as to the suitability of these stocks as an investment. Neither Benzinga nor its staff recommend that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. Benzinga recommends that you conduct your own due diligence and consult a certified financial professional for personalized advice about your financial situation.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.